|
[1]
|
Vu, M., Yu, J., Awolude, O.A. and Chuang, L. (2018) Cervical Cancer Worldwide. Current Problems in Cancer, 42, 457-465. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Liontos, M., Kyriazoglou, A., Dimitriadis, I., Dimopoulos, M. and Bamias, A. (2019) Systemic Therapy in Cervical Cancer: 30 Years in Review. Critical Reviews in Oncology/Hematology, 137, 9-17. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Chargari, C., Peignaux, K., Escande, A., Renard, S., Lafond, C., Petit, A., et al. (2022) Radiotherapy of Cervical Cancer. Cancer/Radiothérapie, 26, 298-308. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Torres Lobaton, A., Rojo Herrera, G., Torres Rojo, A., et al. (2004) [Cervical Cancer. Current View of Its Epidemiology and Risk Factors]. Ginecología y Obstetricia de México, 72, 466-474.
|
|
[5]
|
World Health Organization (2017) Human Papillomavirus Vaccines: WHO Position Paper, May 2017-Recommendations. Vaccine, 35, 5753-5755.
|
|
[6]
|
de Sanjose, S., Quint, W.G., Alemany, L., Geraets, D.T., Klaustermeier, J.E., Lloveras, B., et al. (2010) Human Papillomavirus Genotype Attribution in Invasive Cervical Cancer: A Retrospective Cross-Sectional Worldwide Study. The Lancet Oncology, 11, 1048-1056. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Schiller, J.T., Day, P.M. and Kines, R.C. (2010) Current Understanding of the Mechanism of HPV Infection. Gynecologic Oncology, 118, S12-S17. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
zur Hausen, H. (2002) Papillomaviruses and Cancer: From Basic Studies to Clinical Application. Nature Reviews Cancer, 2, 342-350. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Lei, J., Ploner, A., Elfström, K.M., Wang, J., Roth, A., Fang, F., et al. (2020) HPV Vaccination and the Risk of Invasive Cervical Cancer. New England Journal of Medicine, 383, 1340-1348. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Lichter, K., Krause, D., Xu, J., Tsai, S.H.L., Hage, C., Weston, E., et al. (2020) Adjuvant Human Papillomavirus Vaccine to Reduce Recurrent Cervical Dysplasia in Unvaccinated Women: A Systematic Review and Meta-Analysis. Obstetrics & Gynecology, 135, 1070-1083. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Sweileh, W.M., Al-Jabi, S.W., AbuTaha, A.S., Zyoud, S.H., Anayah, F.M.A. and Sawalha, A.F. (2017) Bibliometric Analysis of Worldwide Scientific Literature in Mobile—Health: 2006-2016. BMC Medical Informatics and Decision Making, 17, Article No. 72. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Durieux, V. and Gevenois, P.A. (2010) Bibliometric Indicators: Quality Measurements of Scientific Publication. Radiology, 255, 342-351. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Rashidi, A., Rahimi, B. and Delirrad, M. (2013) Bibliometric Analysis of Parasitological Research in Iran and Türkiye: A Comparative Study. Iranian Journal of Parasitology, 8, 313-322.
|
|
[15]
|
Ellis, J.T., Ellis, B., Velez-Estevez, A., Reichel, M.P. and Cobo, M.J. (2020) 30 Years of Parasitology Research Analysed by Text Mining. Parasitology, 147, 1643-1657. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Ahmad, T., Imran, M., Ahmad, K., Khan, M., Baig, M., Al-Rifai, R.H., et al. (2021) A Bibliometric Analysis and Global Trends in Fascioliasis Research: A Neglected Tropical Disease. Animals, 11, Article 3385. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Bruel, S., Dutzer, D., Pierre, M., Botelho-Nevers, E., Pozzetto, B., Gagneux-Brunon, A., et al. (2020) Vaccination for Human Papillomavirus: An Historic and Bibliometric Study. Human Vaccines & Immunotherapeutics, 17, 934-942. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Deng, D., Shen, Y., Li, W., Zeng, N., Huang, Y. and Nie, X. (2023) Challenges of Hesitancy in Human Papillomavirus Vaccination: Bibliometric and Visual Analysis. The International Journal of Health Planning and Management, 38, 1161-1183. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Yeung, A.W.K., Tosevska, A., Klager, E., Eibensteiner, F., Laxar, D., Stoyanov, J., et al. (2021) Virtual and Augmented Reality Applications in Medicine: Analysis of the Scientific Literature. Journal of Medical Internet Research, 23, e25499. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Vigliotti, V., Taggart, T., Walker, M., Kusmastuti, S. and Ransome, Y. (2020) Religion, Faith, and Spirituality Influences on HIV Prevention Activities: A Scoping Review. PLOS ONE, 15, e0234720. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Porras, C., Tsang, S.H., Herrero, R., Guillén, D., Darragh, T.M., Stoler, M.H., et al. (2020) Efficacy of the Bivalent HPV Vaccine against HPV 16/18-Associated Precancer: Long-Term Follow-Up Results from the Costa Rica Vaccine Trial. The Lancet Oncology, 21, 1643-1652. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Falagas, M.E., Karavasiou, A.I. and Bliziotis, I.A. (2006) A Bibliometric Analysis of Global Trends of Research Productivity in Tropical Medicine. Acta Tropica, 99, 155-159. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Ellegaard, O. and Wallin, J.A. (2015) The Bibliometric Analysis of Scholarly Production: How Great Is the Impact? Scientometrics, 105, 1809-1831. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Xu, T., Yang, X., He, X. and Wu, J. (2022) The Study on Cervical Cancer Burden in 127 Countries and Its Socioeconomic Influence Factors. Journal of Epidemiology and Global Health, 13, 154-161. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Guillaume, D., Waheed, D., Schlieff, M., Muralidharan, K., Vorsters, A. and Limaye, R. (2022) Key Decision-Making Factors for Human Papillomavirus (HPV) Vaccine Program Introduction in Low-And-Middle-Income-Countries: Global and National Stakeholder Perspectives. Human Vaccines & Immunotherapeutics, 18, Article ID: 2150454. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Bénard, É., Drolet, M., Laprise, J., Jit, M., Prem, K., Boily, M., et al. (2023) Potential Benefit of Extended Dose Schedules of Human Papillomavirus Vaccination in the Context of Scarce Resources and COVID-19 Disruptions in Low-Income and Middle-Income Countries: A Mathematical Modelling Analysis. The Lancet Global Health, 11, e48-e58. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Bosch, F.X., Lorincz, A., Munoz, N., Meijer, C.J.L.M. and Shah, K.V. (2002) The Causal Relation between Human Papillomavirus and Cervical Cancer. Journal of Clinical Pathology, 55, 244-265. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Chaturvedi, A.K., Engels, E.A., Pfeiffer, R.M., Hernandez, B.Y., Xiao, W., Kim, E., et al. (2011) Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States. Journal of Clinical Oncology, 29, 4294-4301. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Casey, S.M., Paiva, T., Perkins, R.B., Villa, A. and Murray, E.J. (2023) Could Oral Health Care Professionals Help Increase Human Papillomavirus Vaccination Rates by Engaging Patients in Discussions? The Journal of the American Dental Association, 154, 10-23.e17. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Karimi Zarchi, M., Behtash, N., Chiti, Z., et al. (2009) Cervical Cancer and HPV Vaccines in Developing Countries. Asian Pacific Journal of Cancer Prevention, 10, 969-974.
|
|
[31]
|
Niewald, A., Oedingen, C. and Razum, O. (2018) Was kann Gesundheitsjournalismus leisten? Eine kriteriengeleitete Bewertung der Berichterstattung zur HPV-Impfung 2006 bis 2009 in Deutschland. Das Gesundheitswesen, 81, 150-156. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Petry, K.U. (2014) HPV and Cervical Cancer. Scandinavian Journal of Clinical and Laboratory Investigation, 74, 59-62. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Moore, D.H. (2006) Cervical Cancer. Obstetrics & Gynecology, 107, 1152-1161. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Mohsen, M.O., Zha, L., Cabral-Miranda, G. and Bachmann, M.F. (2017) Major Findings and Recent Advances in Virus–like Particle (VLP)-Based Vaccines. Seminars in Immunology, 34, 123-132. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Vo, T.P., Panicker, G., Braz-Gomes, K., Parenky, A.C., Rajbhandari, I., Rajeevan, M.S., et al. (2022) Enhanced Immunogenicity of Adjuvanted Microparticulate HPV16 Vaccines Administered via the Transdermal Route. Pharmaceuticals, 15, Article 1128. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Yu, M., Chi, X., Huang, S., Wang, Z., Chen, J., Qian, C., et al. (2022) A Bacterially Expressed Triple-Type Chimeric Vaccine against Human Papillomavirus Types 51, 69, and 26. Vaccine, 40, 6141-6152. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Olczak, P., Wong, M., Tsai, H., Wang, H., Kirnbauer, R., Griffith, A.J., et al. (2022) Vaccination with Human Alphapapillomavirus-Derived L2 Multimer Protects against Human Betapapillomavirus Challenge, Including in Epidermodysplasia Verruciformis Model Mice. Virology, 575, 63-73. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Nhumba, N. and Sunguya, B. (2022) Low Uptake of the Second Dose of Human Papillomavirus Vaccine in Dar Es Salaam, Tanzania. Vaccines, 10, Article 1919. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Simms, K.T., Hanley, S.J.B., Smith, M.A., Keane, A. and Canfell, K. (2020) Impact of HPV Vaccine Hesitancy on Cervical Cancer in Japan: A Modelling Study. The Lancet Public Health, 5, e223-e234. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Smith, D.C., Ruse, D.N. and Zuccolin, D. (1988) Some Characteristics of Glass Ionomer Cement Lining Materials. Journal of the Canadian Dental Association, 54, 903-908.
|
|
[41]
|
Ryan, J. and Malinga, T. (2021) Interventions for Vaccine Hesitancy. Current Opinion in Immunology, 71, 89-91. [Google Scholar] [CrossRef] [PubMed]
|